0001445064-15-000032.txt : 20150203
0001445064-15-000032.hdr.sgml : 20150203
20150203174209
ACCESSION NUMBER: 0001445064-15-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150201
FILED AS OF DATE: 20150203
DATE AS OF CHANGE: 20150203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mallinckrodt plc
CENTRAL INDEX KEY: 0001567892
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981088325
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: DAMASTOWN
STREET 2: MULHUDDART
CITY: DUBLIN
STATE: L2
ZIP: 15
BUSINESS PHONE: 353 1 8808180
MAIL ADDRESS:
STREET 1: DAMASTOWN
STREET 2: MULHUDDART
CITY: DUBLIN
STATE: L2
ZIP: 15
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trudeau Mark
CENTRAL INDEX KEY: 0001540412
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35803
FILM NUMBER: 15572587
MAIL ADDRESS:
STREET 1: COVIDIEN PLC
STREET 2: 15 HAMPSHIRE STREET
CITY: MANSFIELD
STATE: MA
ZIP: 02048
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-02-01
0001567892
Mallinckrodt plc
MNK
0001540412
Trudeau Mark
675 MCDONNELL BLVD.
HAZELWOOD
MO
63042
1
1
0
0
President & CEO
Ordinary Shares
2015-02-01
4
F
0
3440
105.99
D
157197
D
Ordinary Shares
2015-02-02
4
M
0
17904
37.85
A
175101
D
Ordinary Shares
2015-02-02
4
S
0
6625
105.51
D
168476
D
Ordinary Shares
2015-02-02
4
S
0
4200
106.31
D
164276
D
Ordinary Shares
2015-02-02
4
S
0
1100
107.17
D
163176
D
Share Options (Right to Buy)
37.85
2015-02-02
4
M
0
17904
0
A
2013-02-01
2022-01-31
Ordinary Shares
17904
17904
D
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on December 4, 2014.
This represents the weighted average price paid for the shares. The shares were sold at prices ranging from $104.90 to $105.87, inclusive. Mr. Trudeau will provide, upon request of the SEC staff, Mallinckrodt plc, or a shareholder of Mallinckrodt plc complete information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) - (4) to this Form 4.
This represents the weighted average price paid for the shares. The shares were sold at prices ranging from $105.91 to $106.89, inclusive.
This represents the weighted average price paid for the shares. The shares were sold at prices ranging from $106.92 to $107.50, inclusive.
The options representing rights to purchase 71,616 ordinary shares became exercisable in four equal installments beginning on February 1, 2013, which is the first anniversary from the date of the grant.
/s/Peter G. Edwards, Attorney-in-Fact
2015-02-03